News Headlines Article

Good Cholesterol May Not Lower Heart Risk, Study Suggests
San Francisco Chronicle

Raising good cholesterol, a goal pursued by Merck & Co. and Eli Lilly & Co. as the next milestone in cardiac care, may not cut heart attack risk, says a study that challenges the development of drugs that may generate billions of dollars in sales. The report, in the U.K. medical journal The Lancet, found that people with a genetic condition that causes high HDL have the same heart-attack risk as the general population. The results come from a computer analysis of 20 studies.